APRE Archived Articles
Aprea Therapeutics (NASDAQ:APRE): A Precision Oncology Trailblazer Navigating the Synthetic Lethality Frontier
Published on March 12, 2025
Aprea Therapeutics (APRE): A Promising Oncology Player With a Robust Pipeline
Published on November 30, 2024
Aprea Therapeutics, Inc. (NASDAQ:APRE): Advancing Synthetic Lethality Therapies with Promising Pipeline
Published on September 24, 2024